CUTANEOUS AND CLINIC MANIFESTATIONS IN PATIENTS DIAGNOSED WITH COVID19 OF AMAZON: SERIAL CASE REPORT.

Authors

DOI:

https://doi.org/10.47820/recima21.v2i8.635

Keywords:

Rash, COVID-19, Dermatology, Epidemiology, SARS-Cov-2

Abstract

In 2019, a new obscured pneumonia was reported by Wuhan Chinese scientists. Posteriorly, SARS-Cov-2 structure was identified, furthermore the pathology caused by this virus was named as COVID-19. The period of incubation of this disease is something about 4 or 5 days before the onset of symptoms, with 97,5% of patients having 11,5 days of symptoms nearly. Furthermore, affected patients are having cutaneous manifestations, in addition to the classic pulmonary, laboratorial, and systemic affection. Thus, the goal of the present article was the description of the clinical, cutaneous and laboratorial manifestations in adults of 18 to 59 years old affected by COVID19 and supported by São Rafael hospital, localized in Altamira- Pará, a region of Amazon

Downloads

Download data is not yet available.

References

Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet (London, England). 2020;395(10223):470-473.

BRASIL. Secretaria de Políticas de Saúde. Protocolo de manejo clínico do coronavírus (COVID-19) na atenção primária de saúde. Brasília, DF: Ministério da Saúde; 2020.

Chan FW, Shuofeng Y, Kin-Hang K, Kelvin KWT, Hin C, Jin Y, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a Family cluster. Lancet. 2020;395:514–523.

Rachael P, Calvin JC, Barnaby EY, Sarah C, Mark ICC, Hannah EC, et al. Investigation of three clusters of COVID-19 in Singapore:implications for surveillance and response measures. Lancet. 2020;395:1039–1046.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29. PMID: 31995857; PMCID: PMC7121484.

Daniel B, Maria JS, Matthew AS, Swapnil H, Andrew MS, Paul AW, et al. Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology. 2020 may. ASN.2020040419.

Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, et al. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020 Apr 24:10.1111/jdv.16533. doi: 10.1111/jdv.16533. Epub ahead of print. PMID: 32330324; PMCID: PMC7267354.

Bursal DB, Yozgat CY, Yozgat Y, Turel O. Appearance of skin rash in pediatric patients with COVID-19: Three case presentations. Dermatol Ther. 2020 May 15:e13594. doi: 10.1111/dth.13594. Epub ahead of print. PMID: 32412681; PMCID: PMC7261998.

Galván CC, Català A, Carretero HG, Rodríguez‐Jiménez P, Fernández‐Nieto D, Rodríguez‐Villa Lario A, et al. Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183:71-77. doi:10.1111/bjd.19163

Elmas ÖF, Demirbaş A, Özyurt K, Atasoy M, Türsen Ü. Cutaneous manifestations of COVID-19: A review of the published literature. Dermatol Ther. 2020 May 26:e13696. doi: 10.1111/dth.13696. Epub ahead of print. PMID: 32458546; PMCID: PMC7283644.

QUINTANA-CASTANEDO L. et al. Urticarial exanthem as early diagnostic clue for COVID-19 infection. JAAD Case Rep. Abr. 2020;6(6):498-499.

Van DC, Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection. J Eur Acad Dermatol Venereol. 2020 Apr 24:10.1111/jdv.16523. doi: 10.1111/jdv.16523. Epub ahead of print. PMID: 32329915; PMCID: PMC7264566.

Henry D, Ackerman M, Sancelme E, Finon A. and Esteve, E. Urticarial eruption in COVID‐19 infection. J Eur Acad D, et al. Dermatol Venereol. 2020;34:e244-e245. doi:10.1111/jdv.16472.

Gunawan C, Angela A; Widysanto A. Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia. J Eur Acad Dermatol Venereol. 2020 Maio.

Rivera-Oyola R, Koschitzky M, Printy R, Liu S, Stanger R, Golant A, et al. Dermatologic findings in two patients with COVID-19. JAAD Case Rep. 2020 Apr 28;6(6):537–9. doi: 10.1016/j.jdcr.2020.04.027. Epub ahead of print. PMID: 32346588; PMCID: PMC7187826.

Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue. Br J Dermatol. 2020 Jun 1:10.1111/bjd.19264. doi: 10.1111/bjd.19264. Epub ahead of print. PMID: 32479680; PMCID: PMC7300648.

Downloads

Published

12/09/2021

How to Cite

Melo de Souza, T. R., Vale da Luz, P. N., Gadelha Silva, L. M., de Araújo, M. N., da Fonseca, L. G., Batista Lima, K. V., & da Silva Júnior, A. F. (2021). CUTANEOUS AND CLINIC MANIFESTATIONS IN PATIENTS DIAGNOSED WITH COVID19 OF AMAZON: SERIAL CASE REPORT. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 2(8), e28635. https://doi.org/10.47820/recima21.v2i8.635

Issue

Vol. 2 No. 8 (2021): EDITORIAL - CLICK HERE TO ACCESS THE ARTICLES

Section

ARTIGOS

Categories

License

Copyright (c) 2021 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores  e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.